The growth was driven in part by a strong increase in revenues for the company's life sciences research products.
APG Bio will distribute the products and services to life science researchers in China, Hong Kong, and Macau.
The company attributed the decline to lower revenues from its collaboration with Quest Diagnostics.
Product sales rose nearly 23 percent during the year, but this was offset by a 34 percent dip in revenue from an R&D collaboration with Quest Diagnostics.
The French molecular diagnostics company said almost 95 percent of its revenue during the quarter came from its R&D collaboration with Quest Diagnostics.
The company and the hospital will conduct a clinical study into the detection and prevention of the disease.
Under the arrangement, the partners will use Genomic Vision's molecular combing technology to identify genetic variations underlying different diseases.
A 56 percent increase in revenues from the French molecular diagnostic firm's collaboration with Quest Diagnostics drove up overall revenue growth.
The firm said the drop in revenues was due to a lack of milestone payments from Quest Diagnostics, which accounted for half of all revenues in the prior-year period.
Through its agreement with Quest Diagnostics, the company plans to launch a BRCA1/2 test, followed by tests for Lynch syndrome and HPV.
A former Synthetic Genomics attorney alleges that the firm discriminated against her and other female employees, according to the San Diego Union-Tribune.
Due to privacy and lab certification questions, the planned giveaway of Orig3n testing kits at a Baltimore Ravens game was suspended.
Alnylam reports positive results from its phase 3 clinical trial of an RNAi-based drug, according to Stat News.
In Cell this week: adult mesenchymal cell populations in mouse lung, genetic diversity in HPV16 and cancer risk protection, and more.